Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05330442 · ClinicalTrials.gov registry record · NA

Building Experience for Treating Trauma and Enhancing Resilience (BETTER)

A NA study of PTSD, sponsored by RAND.

Active
Registry status
NA
Development phase
720
Enrollment target
10
Study locations

NCT05330442: Active NA study of PTSD, sponsored by RAND.

NCT05330442 is a NA study of PTSD that is active but no longer recruiting, run by RAND. The registered enrollment target is 720 participants, above the 297-participant average among 154 other PTSD trials with a reported enrollment target (142% higher). The trial reports 10 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05330442, a NA study of PTSD, is active but no longer recruiting, sponsored by RAND.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
720 participants
Enrollment target
10
Study locations

Study Summary

Posttraumatic stress disorder (PTSD) is a significant problem among underserved populations who receive care in community health centers. Several evidence-based psychotherapies for PTSD are not practical given the time and resources required for these approaches. This research will examine whether Written Exposure Therapy (WET), a brief and well-tolerated therapy approach, delivered within collaborative primary care is effective and can be implemented successfully within a collaborative care (CC) intervention. The primary aims of the proposed study are to evaluate the effectiveness and implementation of delivering WET into CoCM to improve the management of PTSD among underserved primary care patients in Federally Qualified Health Centers (FQHCs).

Primary Outcome

PTSD symptoms (total score) and provisional diagnosis anchored to the worst traumatic event

Conditions Studied

Interventions

  • BEHAVIORAL Written Exposure Therapy (WET)

Study Locations (10)

New York

  • Oak Orchard Health Center (Albion) - Albion
  • Brownsville Health Center (Genesis and Ashford - BGA) - Brooklyn
  • Brownsville Health Center (Main) - Brooklyn
  • Bedford Stuyvesant Family Health Center (Main) - Brooklyn
  • Bedford Stuyvesant Family Health Center (Sterling and Broadway) - Brooklyn
  • Oak Orchard Health (Pembroke) - Corfu
  • Open Door Family Medical Center (Brewster/Ossining) - Ossining
  • Open Door Family Medical Center (Mamaroneck//Port Chester) - Port Chester

North Carolina

  • OIC Family Medical Center (Fairview) - Rocky Mount
  • OIC Family Medical Center (Happy Hill) - Rocky Mount

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2022-04-25
Est. Completion 2026-06
Phase NA
RAND

78 total trials

What the registry record for NCT05330442 still lists

NCT05330442 is an interventional study that assigns participants to a tested intervention. The registered 720 participants enrollment target is mid-sized for trials with a published cap, above the 297-participant average among 154 other PTSD trials with a reported enrollment target (142% higher).

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Written Exposure Therapy (WET) is the first listed.

NCT05330442 lists 10 locations in 2 states (New York, North Carolina).

Frequently Asked Questions

What is clinical trial NCT05330442 about?

NCT05330442 is a clinical study titled "Building Experience for Treating Trauma and Enhancing Resilience (BETTER)". Posttraumatic stress disorder (PTSD) is a significant problem among underserved populations who receive care in community health centers. Several evidence-based psychotherapies for PTSD are not practical given the time and resources required for these approaches. This research will examine whether W...

What is the current status of trial NCT05330442?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 720 participants. The study started on 2022-04-25. Estimated completion is 2026-06.

What conditions does trial NCT05330442 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT05330442?

The interventions under investigation include: Written Exposure Therapy (WET) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05330442?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05330442 being conducted?

This trial has 10 study locations across New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05330442's enrollment target sits among peer trials

720 8th of 154 higher than 147 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

  • NCT05047224 · 720 participants · NA

    Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

  • NCT05309395 · 720 participants · Phase 3

    Food Prescriptions to Promote Affordable Diets

  • NCT05466214 · 720 participants · NA

    Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Elementary Schools

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05330442, the US trial registry maintained by the National Library of Medicine. NCT05330442 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.